The 5-year survival rate for BC is between 93 and 98%, dependent on patient demographics (e.g., race, ethnicity, age, socioeconomic status, etc.)and tumor morphological properties (e.g., tumor size, local or regional invasion, hormone receptor status, etc.), among other factors. Here, NR4A1 is linked to neoplasm.